PCM
IPXL

Penn Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Penn Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,888
Closed -$383K – 286
2017
Q3 		$383K Sell
18,888
-97,502
-84% -$1.86M 0.03% 248
2017
Q2 		$1.87M Sell
116,390
-151,987
-57% -$2.25M 0.14% 157
2017
Q1 		$3.4M Buy
268,377
+111,948
+72% +$1.35M 0.23% 120
2016
Q4 		$2.07M Sell
156,429
-298,168
-66% -$5.1M 0.13% 170
2016
Q3 		$10.8M Sell
454,597
-47,476
-9% -$1.28M 0.73% 48
2016
Q2 		$14.7M Sell
502,073
-1,823
-0.4% -$59.4K 0.83% 38
2016
Q1 		$16.1M Sell
503,896
-6,739
-1% -$237K 0.92% 35
2015
Q4 		$21.8M Buy
510,635
+61,493
+14% +$2.46M 0.96% 16
2015
Q3 		$15.8M Sell
449,142
-99,569
-18% -$4.49M 0.83% 26
2015
Q2 		$25.2M Sell
548,711
-30,650
-5% -$1.45M 1.04% 13
2015
Q1 		$27.2M Sell
579,361
-129,684
-18% -$5.16M 1.07% 11
2014
Q4 		$22.5M Sell
709,045
-199,550
-22% -$5.84M 0.94% 23
2014
Q3 		$21.5M Buy
908,595
+113,954
+14% +$2.92M 0.9% 23
2014
Q2 		$23.8M Buy
794,641
+235,396
+42% +$6.35M 0.92% 26
2014
Q1 		$14.8M Buy
559,245
+93,330
+20% +$2.33M 0.56% 71
2013
Q4 		$11.7M Buy
+465,915
New +$10.4M 0.42% 92

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Penn Capital Management's IPXL Position: Q4 2017 in Review

Penn Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 18,888 shares — an estimated $383K sold.

Penn Capital Management first reported a position in IPXL in Q4 2013 and held it in 16 quarters. The position peaked at $27.2M in Q1 2015. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Penn Capital Management reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Penn Capital Management sold 18,888 Impax Laboratories, Inc. shares in Q4 2017, an estimated $383K.
  • Penn Capital Management first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 16 quarters.
  • Penn Capital Management's Impax Laboratories, Inc. position peaked at $27.2M in Q1 2015.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Penn Capital Management's 13F filing for Q4 2017, filed 9 Feb 2018.